umr semaglutide coverage and Health Insurance Medicaid Coverage of and Spending

,

Its approval has since expanded to cover: Reducing the risk of major cardiovascular events (stroke or heart attack) in adults with diabetes and known heart disease Reducing the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease (approved January 2025) Heres the complication: Ozempic is not FDA-approved for weight loss , even though many people use it off-label for that purpose

Retatrutide is a once-weekly injection still in clinical trials -but early results (up to 24% body weight loss in 11 months ) are drawing comparisons to bariatric surgery

This 10ml viale contains a sterile liquid containing 0.9% benzyl alcohol (9 mg/mL) and is non-pyrogenic